Document:

EXHIBIT 1-A

 

 

FORM OF

A WARRANT

 

 

WARRANT TO PURCHASE COMMON STOCK

 

 

VOID AFTER 5:00 P.M., NY TIME, ON THE EXPIRATION
DATE

 

THIS WARRANT AND THE SECURITIES ISSUABLE
UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR ANY STATE SECURITIES LAWS. THIS WARRANT AND SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER THE ACT OR
AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE ACT. ANY SUCH TRANSFER MAY ALSO BE SUBJECT TO COMPLIANCE WITH
APPLICABLE STATE SECURITIES LAWS.

 

FOR VALUE RECEIVED,
MEDISTEM, INC., a Nevada corporation (the “Company”), hereby agrees to sell upon the terms and on the conditions hereinafter
set forth, but no later than 5:00 p.m., NY time, on the Expiration Date (as hereinafter defined), to _____________________
(the “Holder”), under the terms as hereinafter set forth, ___________________ fully paid and non-assessable
shares of the Company’s Common Stock, par value $0.0001 per share (the “Warrant Stock”), at a purchase price
of $_____ per share (the “Warrant Price”), pursuant to this warrant (the “Warrant”). The number of shares
of Warrant Stock to be so issued and the Warrant Price are not subject to adjustment in any event as hereinafter set forth. The
term “Common Stock” shall mean, when used herein, unless the context otherwise requires, the stock and other securities
and property at the time receivable upon the exercise of this Warrant.

 

		1.	Exercise of Warrant.

 

a.          The Holder may
exercise this Warrant beginning 12 months after its issuance, i.e. as of __________, 2012, for a period of five years, i.e. until
__________, 2017 (the “Expiration Date”), according to its terms. Exercise of the Warrant shall be by surrendering
said Warrant to the Company at the address set forth in Section 10, together with the form of exercise attached hereto duly executed
by the Holder, accompanied by cash, certified check or bank draft in payment of the Warrant Price, in lawful money of the United
States of America, for the number of shares of the Warrant Stock specified in such form of exercise, or as otherwise provided in
this Warrant.

 

 

 

    	Exhibit 1-A – page 1

    	 

    

b.          This Warrant may
be exercised in whole or in part so long as any exercise in part hereof would not involve the issuance of fractional shares of
Warrant Stock. If exercised in part, the Company shall deliver to the Holder a new Warrant, identical in form, in the name of the
Holder, evidencing the right to purchase the number of shares of Warrant Stock as to which this Warrant has not been exercised,
which new Warrant shall be signed by the Chairman, Chief Executive Officer, President or any Vice President of the Company. The
term Warrant as used herein shall include any subsequent Warrant issued as provided herein.

 

c.          No fractional shares
or scrip representing fractional shares shall be issued upon the exercise of this Warrant. The Company shall pay cash in lieu of
fractions with respect to the Warrants based upon the fair market value of such fractional shares of Common Stock (which shall
be the closing price of such shares on the exchange or market on which the Common Stock is then traded) at the time of exercise
of this Warrant.

 

d.          In the event of
any exercise of the rights represented by this Warrant, a certificate or certificates for the Warrant Stock so purchased, registered
in the name of the Holder, shall be delivered to the Holder within a reasonable time after such rights shall have been so exercised.
Upon exercise of the rights represented by this Warrant, the Holder shall for all purposes be deemed to have become the holder
of record of the shares of Warrant Stock issued upon such exercise immediately prior to the close of business on the date on which
the Warrant was surrendered and payment of the Warrant Price and any applicable taxes was made, irrespective of the date of delivery
of such certificate, except that, if the date of such surrender and payment is a date when the stock transfer books of the Company
are closed, such person shall be deemed to have become the holder of such shares at the opening of business on the next succeeding
date on which the stock transfer books are open. Except as provided in Section 4 hereof, the Company shall pay any and all documentary
stamp or similar issue or transfer taxes payable in respect of the issue or delivery of shares of Common Stock on exercise of this
Warrant; provided, however, that the Company shall not be required to pay any tax that may be payable in respect of any issuance
and delivery of shares of Warrant Stock to any Person other than the Holder or with respect to any income tax due by the Holder
with respect to any shares of Warrant Stock. “Person” shall mean any natural person, corporation, division of a corporation,
partnership, limited liability company, trust, joint venture, association, company, estate, unincorporated organization or government
or any agency or political subdivision thereof.

 

		2.	Disposition of Warrant Stock and Warrant.

 

a.          The Holder hereby
acknowledges that this Warrant and any Warrant Stock purchased pursuant hereto are, as of the date hereof, not registered: (i)
under the Act on the ground that the issuance of this Warrant is exempt from registration under Section 4(2) of the Act as not
involving any public offering or (ii) under any applicable state securities law because the issuance of this Warrant does not involve
any public offering; and that the Company’s reliance on the Section 4(2) exemption of the Act and under applicable state
securities laws is predicated in part on the representations hereby made to the Company by the Holder that it is acquiring this
Warrant and will acquire the Warrant Stock for investment for its own account, with no present intention of dividing its participation
with others or reselling or otherwise distributing the same, subject, nevertheless, to any requirement of law that the disposition
of its property shall at all times be within its control.

 

 

    	Exhibit 1-A – page 2

    	 

    

 

The Holder hereby agrees
that it will not sell or transfer all or any part of this Warrant and/or Warrant Stock, except pursuant to an effective registration
statement under the Act, unless and until it shall first have given notice to the Company describing such sale or transfer and
furnished to the Company either (i) an opinion of counsel for the Company, which the Company shall obtain at its own expense, to
the effect that the proposed sale or transfer may be made without registration under the Act and without registration or qualification
under any state law, or (ii) an interpretative letter from the Securities and Exchange Commission to the effect that no enforcement
action will be recommended if the proposed sale or transfer is made without registration under the Act.

 

b.          If, at the time
of issuance of the shares issuable upon exercise of this Warrant, no registration statement is in effect with respect to such shares
under applicable provisions of the Act, the Company may at its election require that the Holder provide the Company with written
reconfirmation of the Holder’s investment intent and that any stock certificate delivered to the Holder of a surrendered
Warrant shall bear a legend reading substantially as follows:

 

“THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED OR OTHERWISE TRANSFERRED
IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO SUCH SECURITIES UNDER THE ACT OR AN AVAILABLE EXEMPTION FROM
THE REGISTRATION REQUIREMENTS OF THE ACT. ANY SUCH TRANSFER MAY ALSO BE SUBJECT TO COMPLIANCE WITH APPLICABLE STATE SECURITIES
LAWS.”

 

In addition, so long as the foregoing legend
may remain on any stock certificate delivered to the Holder, the Company may maintain appropriate “stop transfer” orders
with respect to such certificates and the shares represented thereby on its books and records and with those to whom it may delegate
registrar and transfer functions.

 

3.          Reservation
of Shares. The Company hereby agrees that at all times there shall be reserved for issuance upon the exercise of this Warrant
such number of shares of its Common Stock as shall be required for issuance upon exercise of this Warrant. The Company further
agrees that all shares which may be issued upon the exercise of the rights represented by this Warrant will be duly authorized
and will, upon issuance and against payment of the Warrant Price therefor, be validly issued, fully paid and non-assessable, free
from all taxes, liens, charges and preemptive rights with respect to the issuance thereof, other than taxes, if any, in respect
of any transfer occurring contemporaneously with such issuance and other than transfer restrictions imposed by federal and state
securities laws.

 

		4.	Exchange, Transfer or Assignment of Warrant.

 

a.          This Warrant is
exchangeable, without expense, at the option of the Holder, upon presentation and surrender hereof to the Company or at the office
of its stock transfer agent, if any, for other Warrants of different denominations, entitling the Holder or Holders thereof to
purchase in the aggregate the same number of shares of Common Stock purchasable hereunder. Upon surrender of this Warrant to the
Company or at the office of its stock transfer agent, if any, with an appropriate instrument of assignment duly executed and funds
sufficient to pay any transfer tax, the Company shall, without charge, execute and deliver a new Warrant in the name of the assignee
named in such instrument of assignment and this Warrant shall promptly be canceled. This Warrant may be divided or combined with
other Warrants that carry the same rights upon presentation hereof at the office of the Company or at the office of its stock transfer
agent, if any, together with a written notice specifying the names and denominations in which new Warrants are to be issued and
signed by the Holder hereof.

 

 

 

    	Exhibit 1-A – page 3

    	 

    

 

b.          Notwithstanding
anything to the contrary contained herein, at such time as this Warrant shall be registered by the Company under the Act, Holder
shall deliver this Warrant to the Company in exchange for a warrant certificate representing the registered warrant, which shall
entitle Holder to purchase the same number of shares of Warrant Stock and at the same Warrant Price as exists at the time of the
surrender.

 

		5.	Notice to Holders.

 

a. Notice of Record Date.
In case: 

 

(i)          the Company shall
take a record of the holders of its Common Stock (or other stock or securities at the time receivable upon the exercise of this
Warrant) for the purpose of entitling them to receive any dividend (other than a cash dividend payable out of earned surplus of
the Company) or other distribution, or any right to subscribe for or purchase any shares of stock of any class or any other securities,
or to receive any other right;

 

(ii)          of any capital
reorganization of the Company, any reclassification of the capital stock of the Company, any consolidation with or merger of the
Company into another Person, or any conveyance of all or substantially all of the assets of the Company to another Person; or

 

(iii)          of any voluntary
dissolution, liquidation or winding-up of the Company;

 

then, and in each such case, the Company
will mail or cause to be mailed to the Holder hereof at the time outstanding a notice specifying, as the case may be, (i) the date
on which a record is to be taken for the purpose of such dividend, distribution or right, and stating the amount and character
of such dividend, distribution or right, or (ii) the date on which such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as of which the holders
of record of Common Stock (or such stock or securities at the time receivable upon the exercise of this Warrant) shall be entitled
to exchange their shares of Common Stock (or such other stock or securities) for securities or other property deliverable upon
such reorganization, reclassification, consolidation, merger, conveyance, dissolution, liquidation or winding-up. Such notice shall
be mailed at least twenty (20) days prior to the record date therein specified, or if no record date shall have been specified
therein, at least twenty (20) days prior to the date of such action, provided, however, failure to provide any such notice shall
not affect the validity of such transaction.

 

 

 

    	Exhibit 1-A – page 4

    	 

    

 

6.          No Rights
as Stockholder. A Warrant does not entitle the Holder thereof to any of the rights of a stockholder of the Company, including,
without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent
or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or
any other matter.

 

7.          Maximum Exercise.
The Holder shall not be entitled to exercise this Warrant on an exercise date, if and to the extent that the number of shares of
Common Stock issuable upon the exercise of this Warrant on such exercise date, together with the number of shares of Common Stock
beneficially owned by the Holder and its affiliates otherwise than on account of ownership of this Warrant on such exercise date,
would result in beneficial ownership by the Holder and its affiliates of more than 4.99% (the “Held Maximum”) of the
outstanding shares of Common Stock on such date. For the purposes of the immediately preceding sentence, beneficial ownership shall
be determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, and Regulation 13d-3 thereunder.
Subject to the foregoing, the Holder shall not be limited to aggregate exercises which would result in the issuance of more than
4.99%. The Company shall waive the restriction described in this Section 8 with respect to any Holder to the extent requested by
such Holder, if and only if the Company receives sixty-one (61) days prior written notice from such Holder requesting such waiver;
provided, however, that the Held Maximum shall in no event be increased to more than 9.99%.

 

8.          Loss, Theft,
Destruction or Mutilation. Upon receipt by the Company of evidence satisfactory to it, in the exercise of its reasonable discretion,
of the ownership and the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction,
of indemnity reasonably satisfactory to the Company (which may include a bond) and, in the case of mutilation, upon surrender and
cancellation hereof, the Company will execute and deliver in lieu hereof, without expense to the Holder, a new Warrant of like
tenor dated the date hereof.

 

9.          Notices.
Any notice required or contemplated by this Warrant shall be deemed to have been duly given if transmitted by registered or certified
mail, return receipt requested, postage prepaid, or nationally recognized overnight delivery service, to the Company at its principal
executive offices: 9255 Towne Centre Drive, Suite 450, San Diego, CA, 92122, Attention: Chief Executive Officer, or to the Holder
at the name and address set forth in the Warrant Register maintained by the Company.

 

10.          Choice of
Law. THIS WARRANT IS ISSUED UNDER AND SHALL FOR ALL PURPOSES BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS
OF THE STATE OF NEVADA, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS OF LAW.

 

 

 

    	Exhibit 1-A – page 5

    	 

    

 

11.          Jurisdiction
and Venue. The Company and the Holder, by its acceptance hereof, hereby agree that any dispute which may arise between them
arising out of or in connection with this Warrant shall be adjudicated before a court located in New York City, New York, and they
hereby submit to the exclusive jurisdiction of the federal and state courts of the State of New York located in New York City with
respect to any action or legal proceeding commenced by any party, and irrevocably waive any objection they now or hereafter may
have respecting the venue of any such action or proceeding brought in such a court or respecting the fact that such court is an
inconvenient forum, relating to or arising out of this Warrant or any acts or omissions relating to the sale of the securities
hereunder, and consent to the service of process in any such action or legal proceeding by means of registered or certified mail,
return receipt requested, postage prepaid, in care of the address set forth herein or such other address as either party shall
furnish in writing to the other.

 

 

 

[Signature Page Follows]

 

 

 

 

 

 

 

 

    	Exhibit 1-A – page 6

    	 

    

 

IN WITNESS WHEREOF, the Company has duly
caused this Warrant to be signed on its behalf, in its corporate name and by its duly authorized officer, as of this 11th day of
March, 2011.

 

 

	 	MEDISTEM, INC.	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	 

 

 

 

 

 

 

 

 

 

 

 

 

    	Exhibit 1-A – page 7

    	 

    

FORM OF EXERCISE

 

(to be executed by the registered holder hereof)

 

 

The undersigned hereby exercises the right
to purchase _________ shares of common stock, par value $0.0001 per share (“Common Stock”), of MediStem, Inc. pursuant
to the provisions of the within Warrant for a Warrant Price of $_____ per share and herewith makes payment of the Warrant Price
in full of $__________.

 

 

	Dated:____________________ , 20__ .	Signature:	 
	 	Name:
	 	 
	 	 
	 	Address:AMENDMENT TO EMPLOYMENT AGREEMENT

 

THIS AMENDMENT (the “Amendment”)
is entered into as of the date set forth below, effective as of August 1st, 2011 (the “Effective
Date”), by and between Brainstorm Cell Therapeutics Ltd., a company organized under the laws of the State of Israel,
with offices at 12 Bazel street Petah-Tikvah, Israel, registered # 513601021, (the "Company") and Adrian Harel
ID# 067490755, of 12/2 Tel Aviv St. Ness Ziona, 74085, Israel ("Employee").

 

WHEREAS, the Company and the Employee
entered into an Employment Agreement, dated January 30 2011 (together with any amendments, exhibits and schedules thereto,
the “Employment Agreement”); and

 

WHEREAS, the Company and the Employee
desire to amend the Employment Agreement on the terms and conditions more fully set forth herein;

 

NOW, THEREFORE, it is hereby agreed
as follows:

 

		1.	Unless otherwise defined herein, all capitalized terms in this Amendment shall have the meanings
ascribed to them in the Employment Agreement.

 

		2.	As of the Effective Date, Employee will be entitled to a monthly gross Salary of 39,000 NIS (in
words: Thirty nine thousand).

 

		3.	Except as set forth herein, the provisions of the Employment Agreement shall remain unchanged and
in full force and effect.

 

 

IN WITNESS WHEREOF,

 

	Company:	 	Employee:
	 	 	 
	Brainstorm Cell Therapeutics Ltd.	 	 
	 	 	Name
	By:	Liat Sossover	 	Adrian Harel
	Title:	Chief Financial Officer	 	/s/ Adrian Harel
	/s/ Liat Sossover	 	Signature
	Signature	 	 
	Date: September 5, 2011	 	Date: September 5, 2011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}]]